1. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats.
- Author
-
Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, and Ginsberg MD
- Subjects
- Animals, Blood Pressure drug effects, Blood Pressure physiology, Body Temperature drug effects, Body Temperature physiology, Bone Morphogenetic Protein 7, Brain metabolism, Brain physiopathology, Brain Ischemia metabolism, Brain Ischemia physiopathology, Cerebrovascular Circulation physiology, Infarction, Middle Cerebral Artery drug therapy, Infarction, Middle Cerebral Artery metabolism, Infarction, Middle Cerebral Artery physiopathology, Male, Movement Disorders drug therapy, Movement Disorders etiology, Movement Disorders physiopathology, Rats, Rats, Sprague-Dawley, Recovery of Function physiology, Bone Morphogenetic Proteins pharmacology, Brain drug effects, Brain Ischemia drug therapy, Cerebrovascular Circulation drug effects, Glucose metabolism, Neuroprotective Agents pharmacology, Recovery of Function drug effects, Transforming Growth Factor beta
- Abstract
Bone morphogenetic protein-7 (BMP-7) has been shown to enhance dendritic growth and improve functional recovery after experimental stroke. In this study, we examined the effect of BMP-7 on functional recovery, local cerebral blood flow (LCBF) and local cerebral glucose utilization (LCMRglu) following transient middle cerebral artery occlusion. Sprague--Dawley rats (n=29) were anesthetized with halothane/nitrous oxide and received 2-h middle cerebral artery occlusion (MCAo) by poly-L-lysine-coated intraluminal suture. Rectal and cranial temperatures were regulated at 37.0--37.5 degrees C. BMP-7 or vehicle (volume, 25 microl) was administered intracisternally in a blinded fashion at 24 h after MCAo. Neurological status was evaluated during occlusion (60 min) and daily for 2 days after MCAo. In matched animal groups, LCMRglu was measured autoradiographically with [(14)C]2-deoxyglucose (2-DG) and LCBF with [(14)C]iodoantipyrine 48 h after MCAo. Four animals groups were studied: LCMRglu series (BMP-7, n=7; vehicle, n=8); LCBF series (BMP-7, n=6; vehicle, n=8). Average three-dimensional image data sets were constructed for each group and were compared by pixel-based statistical methods. Rectal and cranial temperatures, mean blood pressure, plasma glucose and blood gases were similar among groups. BMP-7 significantly improved the total neurological score compared to vehicle at 48 h after MCAo (7.3+/-0.4 vs. 9.0+/-0.2, respectively; P<0.0003). Compared to vehicle-rats, BMP-7 enhanced glucose utilization in the basal ganglia ipsilateral to stroke and improved LCBF in ipsilateral subthalamus, but decreased LCBF and LCMRglu in contralateral cortical regions.
- Published
- 2001
- Full Text
- View/download PDF